Cargando…

Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation

Limosilactobacillus reuteri plays an important role in regulating intestinal functions and maintaining barrier integrity in animals. In this study, Limosilactobacillus reuteri strain SLZX19-12 was isolated from the fecal microbiota of Tibetan pigs, and it was found that this strain is sensitive to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jianmin, Lin, Zishen, Wang, Xian, Zhao, Ying, Zhao, Jinbiao, Liu, Hu, Johnston, Lee J., Lu, Lin, Ma, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241593/
https://www.ncbi.nlm.nih.gov/pubmed/35658572
http://dx.doi.org/10.1128/spectrum.02124-21
_version_ 1784737839672459264
author Wu, Jianmin
Lin, Zishen
Wang, Xian
Zhao, Ying
Zhao, Jinbiao
Liu, Hu
Johnston, Lee J.
Lu, Lin
Ma, Xi
author_facet Wu, Jianmin
Lin, Zishen
Wang, Xian
Zhao, Ying
Zhao, Jinbiao
Liu, Hu
Johnston, Lee J.
Lu, Lin
Ma, Xi
author_sort Wu, Jianmin
collection PubMed
description Limosilactobacillus reuteri plays an important role in regulating intestinal functions and maintaining barrier integrity in animals. In this study, Limosilactobacillus reuteri strain SLZX19-12 was isolated from the fecal microbiota of Tibetan pigs, and it was found that this strain is sensitive to common antibiotics and has strong resistance to stress. Upon being administered by gavage at different doses, including low, medium, and high doses, for 14 days, Limosilactobacillus reuteri SLZX19-12 may enhance the intestinal barrier. After administration of a high dose of SLZX19-12, mice were challenged with Salmonella enterica serovar Typhimurium SL1344. Infection with Salmonella Typhimurium SL1344 led to disordered colonic microbiotas, colonic inflammation through the S100A8/S100A9–NF-κB pathway and potential apoptosis, and translocation of pathogens to parenteral visceral organs in mice. However, the mice pretreated with Limosilactobacillus reuteri SLZX19-12 showed lower loads of Salmonella in visceral organs, less colonic inflammation, and higher barrier integrity. More importantly, the administration of strain SLZX19-12 resulted in a more stable microbiota structure of the colon, in which the abundance of Alloprevotella was greatly enhanced. Therefore, this study suggests that Limosilactobacillus reuteri SLZX19-12 can protect the colon from infection by enhancing the stability of gut microbiota and barrier integrity and reducing inflammation. IMPORTANCE The use of antibiotics to treat bacterial infections leads to a series of side effects. As an alternative method, the biocontrol strategy, which uses probiotics to suppress pathogens, is considered a potential way to deal with bacterial infections in gut. However, there are few probiotics that are currently safe and can protect against infection. In this study, Limosilactobacillus reuteri strain SLZX19-12 was obtained from Tibetan pigs, which have higher resistance to infection. This strain is sensitive to conventional antibiotics, secretes a wide spectrum of enzymes, and also promotes the intestinal barrier function in mice. In addition, Limosilactobacillus reuteri SLZX19-12 can promote the stability of the gut microbiota to avoid or alleviate the occurrence or development of foodborne infections.
format Online
Article
Text
id pubmed-9241593
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-92415932022-06-30 Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation Wu, Jianmin Lin, Zishen Wang, Xian Zhao, Ying Zhao, Jinbiao Liu, Hu Johnston, Lee J. Lu, Lin Ma, Xi Microbiol Spectr Research Article Limosilactobacillus reuteri plays an important role in regulating intestinal functions and maintaining barrier integrity in animals. In this study, Limosilactobacillus reuteri strain SLZX19-12 was isolated from the fecal microbiota of Tibetan pigs, and it was found that this strain is sensitive to common antibiotics and has strong resistance to stress. Upon being administered by gavage at different doses, including low, medium, and high doses, for 14 days, Limosilactobacillus reuteri SLZX19-12 may enhance the intestinal barrier. After administration of a high dose of SLZX19-12, mice were challenged with Salmonella enterica serovar Typhimurium SL1344. Infection with Salmonella Typhimurium SL1344 led to disordered colonic microbiotas, colonic inflammation through the S100A8/S100A9–NF-κB pathway and potential apoptosis, and translocation of pathogens to parenteral visceral organs in mice. However, the mice pretreated with Limosilactobacillus reuteri SLZX19-12 showed lower loads of Salmonella in visceral organs, less colonic inflammation, and higher barrier integrity. More importantly, the administration of strain SLZX19-12 resulted in a more stable microbiota structure of the colon, in which the abundance of Alloprevotella was greatly enhanced. Therefore, this study suggests that Limosilactobacillus reuteri SLZX19-12 can protect the colon from infection by enhancing the stability of gut microbiota and barrier integrity and reducing inflammation. IMPORTANCE The use of antibiotics to treat bacterial infections leads to a series of side effects. As an alternative method, the biocontrol strategy, which uses probiotics to suppress pathogens, is considered a potential way to deal with bacterial infections in gut. However, there are few probiotics that are currently safe and can protect against infection. In this study, Limosilactobacillus reuteri strain SLZX19-12 was obtained from Tibetan pigs, which have higher resistance to infection. This strain is sensitive to conventional antibiotics, secretes a wide spectrum of enzymes, and also promotes the intestinal barrier function in mice. In addition, Limosilactobacillus reuteri SLZX19-12 can promote the stability of the gut microbiota to avoid or alleviate the occurrence or development of foodborne infections. American Society for Microbiology 2022-06-06 /pmc/articles/PMC9241593/ /pubmed/35658572 http://dx.doi.org/10.1128/spectrum.02124-21 Text en Copyright © 2022 Wu et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Wu, Jianmin
Lin, Zishen
Wang, Xian
Zhao, Ying
Zhao, Jinbiao
Liu, Hu
Johnston, Lee J.
Lu, Lin
Ma, Xi
Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation
title Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation
title_full Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation
title_fullStr Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation
title_full_unstemmed Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation
title_short Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation
title_sort limosilactobacillus reuteri slzx19-12 protects the colon from infection by enhancing stability of the gut microbiota and barrier integrity and reducing inflammation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241593/
https://www.ncbi.nlm.nih.gov/pubmed/35658572
http://dx.doi.org/10.1128/spectrum.02124-21
work_keys_str_mv AT wujianmin limosilactobacillusreuterislzx1912protectsthecolonfrominfectionbyenhancingstabilityofthegutmicrobiotaandbarrierintegrityandreducinginflammation
AT linzishen limosilactobacillusreuterislzx1912protectsthecolonfrominfectionbyenhancingstabilityofthegutmicrobiotaandbarrierintegrityandreducinginflammation
AT wangxian limosilactobacillusreuterislzx1912protectsthecolonfrominfectionbyenhancingstabilityofthegutmicrobiotaandbarrierintegrityandreducinginflammation
AT zhaoying limosilactobacillusreuterislzx1912protectsthecolonfrominfectionbyenhancingstabilityofthegutmicrobiotaandbarrierintegrityandreducinginflammation
AT zhaojinbiao limosilactobacillusreuterislzx1912protectsthecolonfrominfectionbyenhancingstabilityofthegutmicrobiotaandbarrierintegrityandreducinginflammation
AT liuhu limosilactobacillusreuterislzx1912protectsthecolonfrominfectionbyenhancingstabilityofthegutmicrobiotaandbarrierintegrityandreducinginflammation
AT johnstonleej limosilactobacillusreuterislzx1912protectsthecolonfrominfectionbyenhancingstabilityofthegutmicrobiotaandbarrierintegrityandreducinginflammation
AT lulin limosilactobacillusreuterislzx1912protectsthecolonfrominfectionbyenhancingstabilityofthegutmicrobiotaandbarrierintegrityandreducinginflammation
AT maxi limosilactobacillusreuterislzx1912protectsthecolonfrominfectionbyenhancingstabilityofthegutmicrobiotaandbarrierintegrityandreducinginflammation